Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design
The human respiratory syncytial virus (hRSV) is the causative agent for high rates of hospitalizations due to viral bronchiolitis and pneumonia worldwide. Such a disease is characterized by an infection of epithelial cells of the distal airways that leads to inflammation and subsequently to respirat...
Main Authors: | Emma Rey-Jurado, Alexis M. Kalergis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/3/556 |
Similar Items
-
Bovine Respiratory Syncytial Virus (BRSV) Pneumonia in Beef Calf Herds Despite Vaccination
by: Pedersen E, et al.
Published: (2001-03-01) -
Respiratory Syncytial Virus Pneumonia During Febrile Neutropenia and Its Treatment
by: Gülcan GÜL, et al.
Published: (2004-06-01) -
Comparison of severe pneumonia caused by Human metapneumovirus and respiratory syncytial virus in hospitalized children
by: Yuqing Wang, et al.
Published: (2014-01-01) -
Respiratory Syncytial Virus: Current Progress in Vaccine Development
by: Julia L. Hurwitz, et al.
Published: (2013-02-01) -
Need for a safe vaccine against respiratory syncytial virus infection
by: Joo-Young Kim, et al.
Published: (2012-09-01)